Oragenics released FY2024 Q4 earnings on March 14 (EST), actual revenue USD 0, actual EPS USD -5.0039

Brief Summary

On March 14, 2025 (US Eastern Time), Oragenics reported its fiscal fourth-quarter 2024 results, showing zero revenue and a net loss of $3.35 million, which translates to a loss per share of $5.0039.

Impact of The News

Event Analysis: Oragenics’ Q4 2024 Financials